Literature DB >> 11858860

Detection of measles vaccine in the throat of a vaccinated child.

Florence Morfin1, Anne Beguin, Bruno Lina, Danielle Thouvenot.   

Abstract

Measles vaccine is widely used, most often in association with mumps and rubella vaccines. We report here the case of a child presenting with fever 8 days after vaccination with a measles-mumps-rubella vaccine. Measles virus was isolated in a throat swab taken 4 days after fever onset. This virus was then further genetically characterised as a vaccine-type virus. Fever occurring subsequent to measles vaccination is related to the replication of the live attenuated vaccine virus. In the case presented here, the vaccine virus was isolated in the throat, showing that subcutaneous injection of an attenuated measles strain can result in respiratory excretion of this virus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858860     DOI: 10.1016/s0264-410x(01)00495-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.

Authors:  Mathieu Mateo; Chanakha K Navaratnarajah; Sabriya Syed; Roberto Cattaneo
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

2.  Nonfebrile seizures after mumps, measles, rubella, and varicella-zoster virus combination vaccination with detection of measles virus RNA in serum, throat, and urine.

Authors:  Isabella Eckerle; Brigitte Keller-Stanislawski; Sabine Santibanez; Stephan Buderus; Matthias Hillmann; Christian Drosten; Anna Maria Eis-Hübinger
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

3.  Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Authors:  Clarisse Lorin; Lawrence Segal; Johann Mols; Danielle Morelle; Patricia Bourguignon; Olga Rovira; Pascal Mettens; Jérémy Silvano; Nicolas Dumey; Frédérick Le Goff; Marguerite Koutsoukos; Gerald Voss; Frédéric Tangy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-16       Impact factor: 3.000

4.  Local public health response to vaccine-associated measles: case report.

Authors:  Monica Hau; Kevin L Schwartz; Crystal Frenette; Isabelle Mogck; Jonathan B Gubbay; Alberto Severini; Joanne Hiebert; Shelley L Deeks; Shaun K Morris
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

Review 5.  Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

Authors:  Aline Baldo; Evanthia Galanis; Frédéric Tangy; Philippe Herman
Journal:  Hum Vaccin Immunother       Date:  2015-12-02       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.